CEO pay league table: biotech hero beats big pharma bosses
This article was originally published in Scrip
Who was the top-paid big pharma executive among in 2012? If you discount Johnson & Johnson's William Weldon, who stood down as CEO in April but continued as chairman until 28 December, taking home $29.8m in total compensation, then it was a near tie, but Abbott Laboratories' Miles White on $25.1m was pipped to the post by Pfizer's Ian Read with $25.6m.
You may also be interested in...
Royal Philips will make 43,000 medical ventilators by year-end for use in the US and make 2,500 more for the Strategic National Stockpile in a deal with the US government worth $646.7m. See what Philips’ CEO Frans van Houten said about it here.
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.